Monthly Archives: September 2017

Nektar – PEGylated opioid analgesic Reported positive Phase 3 clinical trial results

A short polyethylene glycol (PEG) and its pegylation to small molecules could make a huge difference. Nektar announced positive topline results from an oral Human Abuse Potential (HAP) study of NKTR-181, which is a first-in-class opioid analgesic.  NKTR-181 is a … Continue reading

Posted in Blogs | Leave a comment